XENETIC BIOSCIENCES, INC. Cost of Services (Deprecated 2018-01-31)
XENETIC BIOSCIENCES, INC. (XBIO) reported Cost of Services (Deprecated 2018-01-31) of $59.09 thousand for the 3-month period ending 2017-06-30, per its 10-Q filed 2017-08-14.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfServices · last filed 2017-08-14
- XENETIC BIOSCIENCES, INC. cost of services (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $59.09K.
- XENETIC BIOSCIENCES, INC. cost of services (deprecated 2018-01-31) for the quarter ending 2016-06-30 was $0.00.
- XENETIC BIOSCIENCES, INC. cost of services (deprecated 2018-01-31) for the quarter ending 2013-05-31 was $9.93K.
| Period end | Cost of Services (Deprecated 2018-01-31) 3 month | Cost of Services (Deprecated 2018-01-31) 6 month | Cost of Services (Deprecated 2018-01-31) 9 month | Cost of Services (Deprecated 2018-01-31) 22 month |
|---|---|---|---|---|
| 2017-06-30 | $59.09K 10-Q · filed 2017-08-14 | $59.09K 10-Q · filed 2017-08-14 | ||
| 2016-06-30 | $0.00 10-Q · filed 2017-08-14 | $0.00 10-Q · filed 2017-08-14 | ||
| 2013-05-31 | $9.93K 10-Q · filed 2013-07-17 | $9.93K 10-Q · filed 2013-07-17 | $9.93K 10-Q · filed 2013-07-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |